European Commission Biotech initiative must spearhead next wave of EU biosimilar advances for patients and stimulate manufacturing

20 March 2024

Parliament compromise on pharmaceutical legislation accelerates much needed reform

19 March 2024

The enormous and unknown healing power of old medicines (ES)

11 March 2024

The legislative reform being prepared by the EU plans to […]

Parliament’s balanced stand on Unitary SPC regulation rewards innovation via an efficient Unitary SPC system that protects against access to medicines delays

28 February 2024

Changes in medicines procurement policies urgently needed to ensure secure supply of essential medicines

19 February 2024

Health Policy Watch: Forum Discusses High Drug Prices in Wealthy Countries and Access to Medicines in Conflicts

12 February 2024

Adrian van den Hoven, chair of the International Generic and […]

Joint statement Association for Accessible Medicines – Medicines for Europe ahead of 5th EU-U.S. Trade and Technology Council Ministerial meeting

26 January 2024

Court decision on Supplementary Protection Certificate (SPC) manufacturing waiver risks undermining its use

18 January 2024

Medicines for Europe and European Business Association propose priority steps to continue the EU integration of the Ukrainе’s pharmaceutical industry

15 January 2024

The European Union cannot jeopardise patient access to generic medicines through the Urban Wastewater Treatment Directive

8 January 2024